Hiyana Pharmaceuticals India LLP
About Hiyana Pharmaceuticals India LLP
Data last updated:
Hiyana Pharmaceuticals India LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 July 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAX-7251. Its GSTIN is 27AAOFH1787R1ZC (Maharashtra).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Hemil Kirti Shah and Pratik Kirti Shah.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at B404 Rajshree Premises Chsl Opp Shreyas Cinema Lbs Marg Ghatkopar West, Mumbai, Maharashtra, India – 400086.
Company details
Contact details
Hiyana Pharmaceuticals India LLP's registered office is in Mumbai, Maharashtra.
- Registered AddressB404 Rajshree Premises Chsl Opp Shreyas Cinema Lbs Marg Ghatkopar West, Mumbai, Maharashtra, India – 400086
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Hiyana Pharmaceuticals India LLP
FY 2025 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | ||||
| Other Income | ||||
| Total Income | ||||
| Purchases and Direct Costs | ||||
| Personnel Expenses | ||||
| Administrative Expenses | ||||
| Interest | ||||
| Depreciation | ||||
| Total Expenses | ||||
| Profit Before Tax | ||||
| Tax | ||||
| Profit After Tax | ||||
| Profit Transferred to Partners | ||||
| Assets and Liabilities | ||||
| Partners' Contribution | ||||
| Reserves and Surplus | ||||
| Secured Loans | ||||
| Unsecured Loans | ||||
| Trade Payables | ||||
| Other Liabilities and Provisions | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Loans and Advances | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | ||||
| Return on Partners' Funds | ||||
| Return on Assets | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Debt to Partners' Funds | ||||
| Interest Coverage | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Turnover Growth | ||||
| Profit Growth | ||||
To see the full financial statements and ratios of Hiyana Pharmaceuticals India LLP, buy the company report.
Designated partners of Hiyana Pharmaceuticals India LLP
Hiyana Pharmaceuticals India has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemil Kirti Shah Also directs: Prahem Laboratories LLP, Ishpra Pharma LLP | Designated Partner | 09 Jul 2021 | 5 Years 4 Months | Current |
| Pratik Kirti Shah | Designated Partner | 09 Jul 2021 | 5 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Hiyana Pharmaceuticals India LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hiyana Pharmaceuticals India LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hiyana Pharmaceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOFH1787R1ZC | Maharashtra | Active | 01 Oct 2021 |
To see the full GST registrations and return filing status of Hiyana Pharmaceuticals India LLP, buy the company report.
Recent activity
Hiyana Pharmaceuticals India LLP has 2 designated partner changes on record since 2021: 2 appointments. The latest: Hemil Kirti Shah was appointed as Designated Partner on 09 Jul 2021.
Frequently asked questions
Hiyana Pharmaceuticals India is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 09 July 2021 (5+ years old) and is registered under LLPIN AAX-7251.
Hiyana Pharmaceuticals India has 2 current designated partners:
- Hemil Kirti Shah - Designated Partner
- Pratik Kirti Shah - Designated Partner
The latest financial statements of Hiyana Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Hiyana Pharmaceuticals India is 27AAOFH1787R1ZC, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Hiyana Pharmaceuticals India is AAX-7251. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Hiyana Pharmaceuticals India was incorporated on 09 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Hemil Kirti Shah was appointed as Designated Partner on 09 Jul 2021. Pratik Kirti Shah was appointed as Designated Partner on 09 Jul 2021.
The registered office of Hiyana Pharmaceuticals India is at B404 Rajshree Premises Chsl Opp Shreyas Cinema Lbs Marg Ghatkopar West, Mumbai, Maharashtra, India – 400086.
Hiyana Pharmaceuticals India operates in the pharma industry, in the drug formulation and development segment.
Hiyana Pharmaceuticals India can be reached at its registered office: B404 Rajshree Premises Chsl Opp Shreyas Cinema Lbs Marg Ghatkopar West, Mumbai, Maharashtra, India – 400086.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
